TELADOC HEALTH, INC. Cost of Revenue
TELADOC HEALTH, INC. (TDOC) reported Cost of Revenue of $40.03 million for the 3-month period ending 2018-12-31, per its 10-K filed 2019-02-27.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2019-02-27
- TELADOC HEALTH, INC. cost of revenue for the quarter ending 2018-12-31 was $40.03M, a 76.21% increase year-over-year.
- TELADOC HEALTH, INC. cost of revenue for the quarter ending 2018-09-30 was $34.17M, a 104.08% increase year-over-year.
- TELADOC HEALTH, INC. cost of revenue for the quarter ending 2018-06-30 was $27.68M, a 176.12% increase year-over-year.
- TELADOC HEALTH, INC. cost of revenue for the quarter ending 2018-03-31 was $26.86M, a 121.24% increase year-over-year.
- TELADOC HEALTH, INC. cost of revenue for fiscal 2018 was $128.74M, a 108.91% increase from fiscal 2017.
- TELADOC HEALTH, INC. cost of revenue for fiscal 2017 was $61.62M, a 92.75% increase from fiscal 2016.
- TELADOC HEALTH, INC. cost of revenue for fiscal 2016 was $31.97M, a 51.95% increase from fiscal 2015.
- TELADOC HEALTH, INC. cost of revenue for fiscal 2015 was $21.04M, a 111.91% increase from fiscal 2014.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2018-12-31 | $40.03M 10-K · filed 2019-02-27 | $74.19M derived: sum of 2 quarters · filed 2019-02-27 | $101.88M derived: sum of 3 quarters · filed 2019-02-27 | $128.74M 10-K · filed 2019-02-27 |
| 2018-09-30 | $34.17M 10-K · filed 2019-02-27 | $61.85M derived: sum of 2 quarters · filed 2019-02-27 | $88.71M 10-Q · filed 2018-11-01 | $111.42M derived: sum of 4 quarters · filed 2019-02-27 |
| 2018-06-30 | $27.68M 10-K · filed 2019-02-27 | $54.54M 10-Q · filed 2018-08-01 | $77.26M derived: sum of 3 quarters · filed 2019-02-27 | $94.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2018-03-31 | $26.86M 10-K · filed 2019-02-27 | $49.57M derived: sum of 2 quarters · filed 2019-02-27 | $66.31M derived: sum of 3 quarters · filed 2019-02-27 | $76.34M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-12-31 | $22.72M 10-K · filed 2019-02-27 | $39.46M derived: sum of 2 quarters · filed 2019-02-27 | $49.48M derived: sum of 3 quarters · filed 2019-02-27 | $61.62M 10-K · filed 2019-02-27 |
| 2017-09-30 | $16.74M 10-K · filed 2019-02-27 | $26.77M derived: sum of 2 quarters · filed 2019-02-27 | $38.91M 10-Q · filed 2018-11-01 | $48.93M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $10.03M 10-K · filed 2019-02-27 | $22.16M 10-Q · filed 2018-08-01 | $32.19M derived: sum of 3 quarters · filed 2019-02-27 | $39.30M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $12.14M 10-K · filed 2019-02-27 | $22.16M derived: sum of 2 quarters · filed 2019-02-27 | $29.28M derived: sum of 3 quarters · filed 2019-02-27 | $36.17M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $10.03M 10-K · filed 2018-02-27 | $17.14M derived: sum of 2 quarters · filed 2018-02-27 | $24.03M derived: sum of 3 quarters · filed 2018-02-27 | $31.97M 10-K · filed 2019-02-27 |
| 2016-09-30 | $7.11M 10-K · filed 2018-02-27 | $14.00M derived: sum of 2 quarters · filed 2018-02-27 | $21.95M 10-Q · filed 2017-11-01 | $28.42M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $6.89M 10-K · filed 2018-02-27 | $14.83M 10-Q · filed 2017-08-02 | $21.31M derived: sum of 3 quarters · filed 2018-02-27 | $25.80M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $7.94M 10-K · filed 2018-02-27 | $14.42M derived: sum of 2 quarters · filed 2018-02-27 | $18.91M derived: sum of 3 quarters · filed 2018-02-27 | $23.70M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $6.48M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $10.97M derived: sum of 2 quarters · filed 2018-02-27 | $15.76M derived: sum of 3 quarters · filed 2018-02-27 | $21.04M 10-K · filed 2018-02-27 |
| 2015-09-30 | $4.49M 10-Q · filed 2016-10-27 | $9.28M derived: sum of 2 quarters · filed 2016-10-27 | $14.56M 10-Q · filed 2016-10-27 | $18.33M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $4.79M 10-Q · filed 2016-08-03 | $10.07M 10-Q · filed 2016-08-03 | $13.84M derived: sum of 3 quarters · filed 2017-03-01 | $15.99M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $5.28M 10-Q · filed 2016-05-10 | $9.05M derived: sum of 2 quarters · filed 2017-03-01 | $11.20M derived: sum of 3 quarters · filed 2017-03-01 | $13.23M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $3.77M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $5.92M derived: sum of 2 quarters · filed 2017-03-01 | $7.95M derived: sum of 3 quarters · filed 2017-03-01 | $9.93M 10-K · filed 2017-03-01 |
| 2014-09-30 | $2.15M 10-Q · filed 2015-11-02 | $4.18M derived: sum of 2 quarters · filed 2015-11-02 | $6.16M 10-Q · filed 2015-11-02 | |
| 2014-06-30 | $2.03M 10-Q · filed 2015-08-12 | $4.01M 10-Q · filed 2015-08-12 | ||
| 2013-12-31 | $4.19M 10-K · filed 2016-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |